Pneumonia

MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine

by

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries Barcelona – As governments and the global vaccines community gather this week at the first ever Global Forum on Childhood Pneumonia in Barcelona, Doctors Without Borders/Médecins Sans Frontières (MSF) urges Gavi, the … Read more

Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine

by

Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to make sure the 55 million children who do not have access to the pneumonia vaccine … Read more

MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumonia vaccine

by

New Delhi – Ahead of this week’s board meeting of Gavi, the Vaccine Alliance, in New Delhi, India, Doctors without Borders/Médecins Sans Frontières (MSF) called on board members to immediately stop paying out funds from a remaining US$262 million subsidy to the pharmaceutical corporations Pfizer and GlaxoSmithKline (GSK) for the pneumococcal vaccine. MSF called for … Read more

Indian patent office delivers major blow to affordable pneumonia vaccine hopes

by

Geneva/New York/New Delhi, 22 August 2017 – Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia were dealt a major blow after the Indian patent office granted a patent to the US pharmaceutical corporation Pfizer for its PCV13 product, marketed as Prevnar13. “It’s unfair and … Read more